OM-85/Broncho-Vaxom

About OM Pharma

OM Pharma is a long-established Swiss biopharmaceutical company with a specialized focus on bacterial immunotherapies for infection prevention and vascular diseases. Its core business model revolves around developing and commercializing immunomodulatory products, primarily derived from bacterial lysates, to train the immune system. The company has a global commercial footprint with a portfolio of approved products, positioning it in the 'Commercial' stage. As a private company, it leverages decades of experience in microbial-based therapeutics.

Therapeutic Areas